SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-053977
Filing Date
2024-05-07
Accepted
2024-05-07 08:26:16
Documents
51
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cogt-20240331.htm   iXBRL 10-Q 1165219
2 EX-31.1 cogt-ex31_1.htm EX-31.1 12891
3 EX-31.2 cogt-ex31_2.htm EX-31.2 12879
4 EX-32.1 cogt-ex32_1.htm EX-32.1 8160
5 EX-32.2 cogt-ex32_2.htm EX-32.2 8135
6 GRAPHIC img158365077_0.jpg GRAPHIC 566283
  Complete submission text file 0000950170-24-053977.txt   6346723

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cogt-20240331.xsd EX-101.SCH 873760
54 EXTRACTED XBRL INSTANCE DOCUMENT cogt-20240331_htm.xml XML 718901
Mailing Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451
Business Address 275 WYMAN STREET 3RD FLOOR WALTHAM MA 02451 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38443 | Film No.: 24919748
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)